[Federal Register Volume 89, Number 27 (Thursday, February 8, 2024)]
[Notices]
[Pages 8691-8692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Eunice Kennedy Shriver National Institute of 
Child Health and Human Development Special Emphasis Panel; HEAL 
Initiative: Limited Competition: Clinical Outcomes of Babies with 
Opioid Exposure (OBOE) Study (UG1).
    Date: March 25, 2024.
    Time: 9:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, 6710B 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kimberly L. Houston, M.D., Scientific Review 
Branch, Eunice Kennedy Shriver National Institute of Child Health & 
Human Development, NIH, 6710B Rockledge Drive, Rm. 2137C, Bethesda, 
MD 20892, (301) 827-4902, [email protected].


[[Page 8692]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: February 2, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02525 Filed 2-7-24; 8:45 am]
BILLING CODE 4140-01-P